+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Long-acting PrEP Market - Global Forecast 2025-2030- Product Image
Long-acting PrEP Market - Global Forecast 2025-2030- Product Image
Sale

Long-acting PrEP Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 184 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6118487
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Long-acting pre-exposure prophylaxis (PrEP) is fundamentally transforming HIV prevention, delivering sustained protection with extended dosing intervals. This pivotal market shift addresses the growing need for patient-centric interventions in preventive care, aligning with evolving clinical, regulatory, and supply chain realities.

Market Snapshot: Long-Acting PrEP Market Overview

The long-acting PrEP market is characterized by rapid innovation, shaped by breakthroughs in biodegradable implants and advanced injectable formulations. Spurred by rising adoption, the sector is enabled by streamlined clinical approval processes, expanding reimbursement models, and increased engagement from primary healthcare, public agencies, and NGOs. As global health systems shift from daily pill adherence models to long-lasting preventive therapeutics, manufacturers and distributors are aligning supply infrastructure and patient services to meet sustained demand. Market growth is further strengthened by collaborative efforts across regulatory and policy environments.

Scope & Segmentation in Long-Acting PrEP

  • Product Types: Includes both biodegradable and non-biodegradable implants, as well as intramuscular and subcutaneous injectable options.
  • Distribution Channels: Community health centers, hospital pharmacies, certified online pharmacies, and retail pharmacies (chain and independent).
  • End Users: Private and public hospitals, international and local NGOs, specialized sexual health and STD clinics, and public health programs.
  • Target Populations: Adolescents (ages 15–19, 20–24), heterosexual adults (ages 25–49, 50+), and adult or young men who have sex with men.
  • Administration Settings: Clinical settings such as clinics and hospitals, as well as home-based nurse-assisted or self-administered models.
  • Geographic Coverage: Americas (with focused markets including the United States—California, Texas, New York, Florida, Illinois, Pennsylvania, Ohio—Canada, Mexico, Brazil, Argentina); Europe, Middle East & Africa (United Kingdom, Germany, France, Russia, Italy, Spain, United Arab Emirates, Saudi Arabia, South Africa, and others); Asia-Pacific (China, India, Japan, Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam, Taiwan).
  • Key Companies Profiled: ViiV Healthcare Limited, Merck & Co., Inc., Gilead Sciences, Inc., Janssen Pharmaceutica NV, Viatris Inc., Teva Pharmaceutical Industries Limited, Cipla Limited, Lupin Limited, Sandoz International GmbH, Serum Institute of India Private Limited.

Key Takeaways for Decision-Makers

  • Long-acting PrEP adoption is rapidly scaling due to the convergence of innovative delivery systems, patient preference for convenience, and increasing investments in preventive healthcare infrastructure.
  • Integrating digital health platforms enhances real-world adherence, reduces loss to follow-up, and supports sustained engagement among high-risk populations.
  • Collaborations between manufacturers, NGOs, and public health agencies expand access through tailored procurement and distribution models, reaching underserved groups and reducing the impact of stigma.
  • Localized manufacturing and agile supply chain design help reduce vulnerability to regulatory changes and external cost pressures.
  • Emerging distribution models, such as mobile outreach and certified online pharmacies, are expanding reach in both high-density urban centers and remote settings.

Tariff Impact: United States Market, 2025

The rollout of new United States tariffs in early 2025 introduced notable cost pressures on long-acting PrEP manufacturers through increased prices for active pharmaceutical ingredients and imported device components. This prompted supply chain restructuring, with companies focusing on domestic sourcing, renegotiating contracts, and innovating in alternative materials to maintain competitive pricing. Distributors adapted logistics, leveraging bonded storage and consolidated shipments, while payers and procurement entities re-evaluated purchasing strategies—shifting to pooled and multi-year agreements to stabilize costs.

Methodology & Data Sources

This report synthesizes findings from structured interviews, subject-matter expert panels, and targeted surveys across the pharmaceutical and healthcare sectors. Primary research was rigorously cross-validated with systematic reviews of peer-reviewed literature, regulatory documentation, and proprietary trade and logistics data. Data interpretation was supported by robust analytical frameworks and consensus-building through multi-round expert input.

Why This Report Matters

  • Enables health sector leaders and procurement managers to align innovation, access, and supply chain resilience strategies with evolving regulatory and market dynamics.
  • Provides comprehensive, region-specific analysis to tailor entry, distribution, and engagement approaches for diverse public health landscapes.

Conclusion

With the long-acting PrEP market rapidly evolving, senior decision-makers are equipped with the segmentation insights and actionable strategies needed to optimize patient engagement and accelerate progress toward comprehensive HIV prevention. This report empowers leaders to proactively address market complexity and realize both impact and operational advantage.



This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Expansion of long-acting cabotegravir injectable uptake across urban and underserved populations driven by targeted community outreach
5.2. Development of implantable long-acting PrEP delivery systems enabling multi-month protection and reducing adherence burdens
5.3. Growing telehealth models integrating home testing kits and virtual consultations for PrEP initiation and follow-up care
5.4. Entry of biosimilar and generic long-acting PrEP formulations intensifying price competition and improving market accessibility
5.5. Increased incorporation of digital adherence monitoring tools using smart injectors and mobile app reminders for PrEP users
5.6. Strategic partnerships between pharmaceutical companies and global health organizations to scale long-acting PrEP in low-income regions
5.7. Impact of updated WHO and CDC guidelines endorsing injectable PrEP on payer reimbursement policies and clinical adoption rates
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Long-acting PrEP Market, by Product Type
8.1. Introduction
8.2. Implant
8.2.1. Biodegradable
8.2.2. Non-Biodegradable
8.3. Injectable
8.3.1. Intramuscular
8.3.2. Subcutaneous
9. Long-acting PrEP Market, by Distribution Channel
9.1. Introduction
9.2. Community Health Centers
9.2.1. Fixed Clinics
9.2.2. Mobile Clinics
9.3. Hospital Pharmacies
9.3.1. Private Hospitals
9.3.2. Public Hospitals
9.4. Online Pharmacies
9.4.1. Certified Online Pharmacies
9.5. Retail Pharmacies
9.5.1. Chain Pharmacies
9.5.2. Independent Pharmacies
10. Long-acting PrEP Market, by End User
10.1. Introduction
10.2. Hospitals
10.2.1. Private Hospitals
10.2.2. Public Hospitals
10.3. NGOs
10.3.1. International NGOs
10.3.2. Local NGOs
10.4. Private Clinics
10.4.1. Sexual Health Clinics
10.4.2. STD Clinics
10.5. Public Health Programs
10.5.1. Community Outreach Programs
10.5.2. Government Funded Programs
11. Long-acting PrEP Market, by Target Population
11.1. Introduction
11.2. Adolescents
11.2.1. 15 To 19
11.2.2. 20 To 24
11.3. Heterosexual Adults
11.3.1. 25 To 49
11.3.2. 50 Plus
11.4. Men Who Have Sex With Men
11.4.1. Adult MSM
11.4.2. Young MSM
12. Long-acting PrEP Market, by Administration Setting
12.1. Introduction
12.2. Clinical Setting
12.2.1. Clinic
12.2.2. Hospital
12.3. Home Based
12.3.1. Nurse Assisted Administration
12.3.2. Self Administration
13. Americas Long-acting PrEP Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Long-acting PrEP Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Long-acting PrEP Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. ViiV Healthcare Limited
16.3.2. Merck & Co., Inc.
16.3.3. Gilead Sciences, Inc.
16.3.4. Janssen Pharmaceutica NV
16.3.5. Viatris Inc.
16.3.6. Teva Pharmaceutical Industries Limited
16.3.7. Cipla Limited
16.3.8. Lupin Limited
16.3.9. Sandoz International GmbH
16.3.10. Serum Institute of India Private Limited
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. LONG-ACTING PREP MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL LONG-ACTING PREP MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL LONG-ACTING PREP MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL LONG-ACTING PREP MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL LONG-ACTING PREP MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL LONG-ACTING PREP MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL LONG-ACTING PREP MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 8. GLOBAL LONG-ACTING PREP MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL LONG-ACTING PREP MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL LONG-ACTING PREP MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL LONG-ACTING PREP MARKET SIZE, BY TARGET POPULATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL LONG-ACTING PREP MARKET SIZE, BY TARGET POPULATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL LONG-ACTING PREP MARKET SIZE, BY ADMINISTRATION SETTING, 2024 VS 2030 (%)
FIGURE 14. GLOBAL LONG-ACTING PREP MARKET SIZE, BY ADMINISTRATION SETTING, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS LONG-ACTING PREP MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS LONG-ACTING PREP MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES LONG-ACTING PREP MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES LONG-ACTING PREP MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA LONG-ACTING PREP MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA LONG-ACTING PREP MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC LONG-ACTING PREP MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC LONG-ACTING PREP MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. LONG-ACTING PREP MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. LONG-ACTING PREP MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. LONG-ACTING PREP MARKET: RESEARCHAI
FIGURE 26. LONG-ACTING PREP MARKET: RESEARCHSTATISTICS
FIGURE 27. LONG-ACTING PREP MARKET: RESEARCHCONTACTS
FIGURE 28. LONG-ACTING PREP MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. LONG-ACTING PREP MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL LONG-ACTING PREP MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL LONG-ACTING PREP MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL LONG-ACTING PREP MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL LONG-ACTING PREP MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL LONG-ACTING PREP MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL LONG-ACTING PREP MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL LONG-ACTING PREP MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL LONG-ACTING PREP MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL LONG-ACTING PREP MARKET SIZE, BY IMPLANT, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL LONG-ACTING PREP MARKET SIZE, BY IMPLANT, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL LONG-ACTING PREP MARKET SIZE, BY BIODEGRADABLE, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL LONG-ACTING PREP MARKET SIZE, BY BIODEGRADABLE, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL LONG-ACTING PREP MARKET SIZE, BY NON-BIODEGRADABLE, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL LONG-ACTING PREP MARKET SIZE, BY NON-BIODEGRADABLE, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL LONG-ACTING PREP MARKET SIZE, BY IMPLANT, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL LONG-ACTING PREP MARKET SIZE, BY IMPLANT, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL LONG-ACTING PREP MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL LONG-ACTING PREP MARKET SIZE, BY INJECTABLE, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL LONG-ACTING PREP MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL LONG-ACTING PREP MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL LONG-ACTING PREP MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL LONG-ACTING PREP MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL LONG-ACTING PREP MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL LONG-ACTING PREP MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL LONG-ACTING PREP MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL LONG-ACTING PREP MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL LONG-ACTING PREP MARKET SIZE, BY COMMUNITY HEALTH CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL LONG-ACTING PREP MARKET SIZE, BY COMMUNITY HEALTH CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL LONG-ACTING PREP MARKET SIZE, BY FIXED CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL LONG-ACTING PREP MARKET SIZE, BY FIXED CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL LONG-ACTING PREP MARKET SIZE, BY MOBILE CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL LONG-ACTING PREP MARKET SIZE, BY MOBILE CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL LONG-ACTING PREP MARKET SIZE, BY COMMUNITY HEALTH CENTERS, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL LONG-ACTING PREP MARKET SIZE, BY COMMUNITY HEALTH CENTERS, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL LONG-ACTING PREP MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL LONG-ACTING PREP MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL LONG-ACTING PREP MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL LONG-ACTING PREP MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL LONG-ACTING PREP MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL LONG-ACTING PREP MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL LONG-ACTING PREP MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL LONG-ACTING PREP MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL LONG-ACTING PREP MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL LONG-ACTING PREP MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL LONG-ACTING PREP MARKET SIZE, BY CERTIFIED ONLINE PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL LONG-ACTING PREP MARKET SIZE, BY CERTIFIED ONLINE PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL LONG-ACTING PREP MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL LONG-ACTING PREP MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL LONG-ACTING PREP MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL LONG-ACTING PREP MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL LONG-ACTING PREP MARKET SIZE, BY CHAIN PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL LONG-ACTING PREP MARKET SIZE, BY CHAIN PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL LONG-ACTING PREP MARKET SIZE, BY INDEPENDENT PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL LONG-ACTING PREP MARKET SIZE, BY INDEPENDENT PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL LONG-ACTING PREP MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL LONG-ACTING PREP MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL LONG-ACTING PREP MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL LONG-ACTING PREP MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL LONG-ACTING PREP MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL LONG-ACTING PREP MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL LONG-ACTING PREP MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL LONG-ACTING PREP MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL LONG-ACTING PREP MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL LONG-ACTING PREP MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL LONG-ACTING PREP MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL LONG-ACTING PREP MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL LONG-ACTING PREP MARKET SIZE, BY NGOS, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL LONG-ACTING PREP MARKET SIZE, BY NGOS, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL LONG-ACTING PREP MARKET SIZE, BY INTERNATIONAL NGOS, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL LONG-ACTING PREP MARKET SIZE, BY INTERNATIONAL NGOS, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL LONG-ACTING PREP MARKET SIZE, BY LOCAL NGOS, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL LONG-ACTING PREP MARKET SIZE, BY LOCAL NGOS, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL LONG-ACTING PREP MARKET SIZE, BY NGOS, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL LONG-ACTING PREP MARKET SIZE, BY NGOS, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL LONG-ACTING PREP MARKET SIZE, BY PRIVATE CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL LONG-ACTING PREP MARKET SIZE, BY PRIVATE CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL LONG-ACTING PREP MARKET SIZE, BY SEXUAL HEALTH CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL LONG-ACTING PREP MARKET SIZE, BY SEXUAL HEALTH CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL LONG-ACTING PREP MARKET SIZE, BY STD CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL LONG-ACTING PREP MARKET SIZE, BY STD CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL LONG-ACTING PREP MARKET SIZE, BY PRIVATE CLINICS, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL LONG-ACTING PREP MARKET SIZE, BY PRIVATE CLINICS, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL LONG-ACTING PREP MARKET SIZE, BY PUBLIC HEALTH PROGRAMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL LONG-ACTING PREP MARKET SIZE, BY PUBLIC HEALTH PROGRAMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL LONG-ACTING PREP MARKET SIZE, BY COMMUNITY OUTREACH PROGRAMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL LONG-ACTING PREP MARKET SIZE, BY COMMUNITY OUTREACH PROGRAMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL LONG-ACTING PREP MARKET SIZE, BY GOVERNMENT FUNDED PROGRAMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL LONG-ACTING PREP MARKET SIZE, BY GOVERNMENT FUNDED PROGRAMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL LONG-ACTING PREP MARKET SIZE, BY PUBLIC HEALTH PROGRAMS, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL LONG-ACTING PREP MARKET SIZE, BY PUBLIC HEALTH PROGRAMS, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL LONG-ACTING PREP MARKET SIZE, BY TARGET POPULATION, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL LONG-ACTING PREP MARKET SIZE, BY TARGET POPULATION, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL LONG-ACTING PREP MARKET SIZE, BY ADOLESCENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL LONG-ACTING PREP MARKET SIZE, BY ADOLESCENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL LONG-ACTING PREP MARKET SIZE, BY 15 TO 19, BY REGION, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL LONG-ACTING PREP MARKET SIZE, BY 15 TO 19, BY REGION, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL LONG-ACTING PREP MARKET SIZE, BY 20 TO 24, BY REGION, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL LONG-ACTING PREP MARKET SIZE, BY 20 TO 24, BY REGION, 2025-2030 (USD MILLION)
TABLE 101. GLOBAL LONG-ACTING PREP MARKET SIZE, BY ADOLESCENTS, 2018-2024 (USD MILLION)
TABLE 102. GLOBAL LONG-ACTING PREP MARKET SIZE, BY ADOLESCENTS, 2025-2030 (USD MILLION)
TABLE 103. GLOBAL LONG-ACTING PREP MARKET SIZE, BY HETEROSEXUAL ADULTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 104. GLOBAL LONG-ACTING PREP MARKET SIZE, BY HETEROSEXUAL ADULTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 105. GLOBAL LONG-ACTING PREP MARKET SIZE, BY 25 TO 49, BY REGION, 2018-2024 (USD MILLION)
TABLE 106. GLOBAL LONG-ACTING PREP MARKET SIZE, BY 25 TO 49, BY REGION, 2025-2030 (USD MILLION)
TABLE 107. GLOBAL LONG-ACTING PREP MARKET SIZE, BY 50 PLUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 108. GLOBAL LONG-ACTING PREP MARKET SIZE, BY 50 PLUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 109. GLOBAL LONG-ACTING PREP MARKET SIZE, BY HETEROSEXUAL ADULTS, 2018-2024 (USD MILLION)
TABLE 110. GLOBAL LONG-ACTING PREP MARKET SIZE, BY HETEROSEXUAL ADULTS, 2025-2030 (USD MILLION)
TABLE 111. GLOBAL LONG-ACTING PREP MARKET SIZE, BY MEN WHO HAVE SEX WITH MEN, BY REGION, 2018-2024 (USD MILLION)
TABLE 112. GLOBAL LONG-ACTING PREP MARKET SIZE, BY MEN WHO HAVE SEX WITH MEN, BY REGION, 2025-2030 (USD MILLION)
TABLE 113. GLOBAL LONG-ACTING PREP MARKET SIZE, BY ADULT MSM, BY REGION, 2018-2024 (USD MILLION)
TABLE 114. GLOBAL LONG-ACTING PREP MARKET SIZE, BY ADULT MSM, BY REGION, 2025-2030 (USD MILLION)
TABLE 115. GLOBAL LONG-ACTING PREP MARKET SIZE, BY YOUNG MSM, BY REGION, 2018-2024 (USD MILLION)
TABLE 116. GLOBAL LONG-ACTING PREP MARKET SIZE, BY YOUNG MSM, BY REGION, 2025-2030 (USD MILLION)
TABLE 117. GLOBAL LONG-ACTING PREP MARKET SIZE, BY MEN WHO HAVE SEX WITH MEN, 2018-2024 (USD MILLION)
TABLE 118. GLOBAL LONG-ACTING PREP MARKET SIZE, BY MEN WHO HAVE SEX WITH MEN, 2025-2030 (USD MILLION)
TABLE 119. GLOBAL LONG-ACTING PREP MARKET SIZE, BY ADMINISTRATION SETTING, 2018-2024 (USD MILLION)
TABLE 120. GLOBAL LONG-ACTING PREP MARKET SIZE, BY ADMINISTRATION SETTING, 2025-2030 (USD MILLION)
TABLE 121. GLOBAL LONG-ACTING PREP MARKET SIZE, BY CLINICAL SETTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 122. GLOBAL LONG-ACTING PREP MARKET SIZE, BY CLINICAL SETTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 123. GLOBAL LONG-ACTING PREP MARKET SIZE, BY CLINIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 124. GLOBAL LONG-ACTING PREP MARKET SIZE, BY CLINIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 125. GLOBAL LONG-ACTING PREP MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 126. GLOBAL LONG-ACTING PREP MARKET SIZE, BY HOSPITAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 127. GLOBAL LONG-ACTING PREP MARKET SIZE, BY CLINICAL SETTING, 2018-2024 (USD MILLION)
TABLE 128. GLOBAL LONG-ACTING PREP MARKET SIZE, BY CLINICAL SETTING, 2025-2030 (USD MILLION)
TABLE 129. GLOBAL LONG-ACTING PREP MARKET SIZE, BY HOME BASED, BY REGION, 2018-2024 (USD MILLION)
TABLE 130. GLOBAL LONG-ACTING PREP MARKET SIZE, BY HOME BASED, BY REGION, 2025-2030 (USD MILLION)
TABLE 131. GLOBAL LONG-ACTING PREP MARKET SIZE, BY NURSE ASSISTED ADMINISTRATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 132. GLOBAL LONG-ACTING PREP MARKET SIZE, BY NURSE ASSISTED ADMINISTRATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 133. GLOBAL LONG-ACTING PREP MARKET SIZE, BY SELF ADMINISTRATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 134. GLOBAL LONG-ACTING PREP MARKET SIZE, BY SELF ADMINISTRATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 135. GLOBAL LONG-ACTING PREP MARKET SIZE, BY HOME BASED, 2018-2024 (USD MILLION)
TABLE 136. GLOBAL LONG-ACTING PREP MARKET SIZE, BY HOME BASED, 2025-2030 (USD MILLION)
TABLE 137. AMERICAS LONG-ACTING PREP MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 138. AMERICAS LONG-ACTING PREP MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 139. AMERICAS LONG-ACTING PREP MARKET SIZE, BY IMPLANT, 2018-2024 (USD MILLION)
TABLE 140. AMERICAS LONG-ACTING PREP MARKET SIZE, BY IMPLANT, 2025-2030 (USD MILLION)
TABLE 141. AMERICAS LONG-ACTING PREP MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 142. AMERICAS LONG-ACTING PREP MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 143. AMERICAS LONG-ACTING PREP MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 144. AMERICAS LONG-ACTING PREP MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 145. AMERICAS LONG-ACTING PREP MARKET SIZE, BY COMMUNITY HEALTH CENTERS, 2018-2024 (USD MILLION)
TABLE 146. AMERICAS LONG-ACTING PREP MARKET SIZE, BY COMMUNITY HEALTH CENTERS, 2025-2030 (USD MILLION)
TABLE 147. AMERICAS LONG-ACTING PREP MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 148. AMERICAS LONG-ACTING PREP MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 149. AMERICAS LONG-ACTING PREP MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 150. AMERICAS LONG-ACTING PREP MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 151. AMERICAS LONG-ACTING PREP MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 152. AMERICAS LONG-ACTING PREP MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 153. AMERICAS LONG-ACTING PREP MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 154. AMERICAS LONG-ACTING PREP MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 155. AMERICAS LONG-ACTING PREP MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 156. AMERICAS LONG-ACTING PREP MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 157. AMERICAS LONG-ACTING PREP MARKET SIZE, BY NGOS, 2018-2024 (USD MILLION)
TABLE 158. AMERICAS LONG-ACTING PREP MARKET SIZE, BY NGOS, 2025-2030 (USD MILLION)
TABLE 159. AMERICAS LONG-ACTING PREP MARKET SIZE, BY PRIVATE CLINICS, 2018-2024 (USD MILLION)
TABLE 160. AMERICAS LONG-ACTING PREP MARKET SIZE, BY PRIVATE CLINICS, 2025-2030 (USD MILLION)
TABLE 161. AMERICAS LONG-ACTING PREP MARKET SIZE, BY PUBLIC HEALTH PROGRAMS, 2018-2024 (USD MILLION)
TABLE 162. AMERICAS LONG-ACTING PREP MARKET SIZE, BY PUBLIC HEALTH PROGRAMS, 2025-2030 (USD MILLION)
TABLE 163. AMERICAS LONG-ACTING PREP MARKET SIZE, BY TARGET POPULATION, 2018-2024 (USD MILLION)
TABLE 164. AMERICAS LONG-ACTING PREP MARKET SIZE, BY TARGET POPULATION, 2025-2030 (USD MILLION)
TABLE 165. AMERICAS LONG-ACTING PREP MARKET SIZE, BY ADOLESCENTS, 2018-2024 (USD MILLION)
TABLE 166. AMERICAS LONG-ACTING PREP MARKET SIZE, BY ADOLESCENTS, 2025-2030 (USD MILLION)
TABLE 167. AMERICAS LONG-ACTING PREP MARKET SIZE, BY HETEROSEXUAL ADULTS, 2018-2024 (USD MILLION)
TABLE 168. AMERICAS LONG-ACTING PREP MARKET SIZE, BY HETEROSEXUAL ADULTS, 2025-2030 (USD MILLION)
TABLE 169. AMERICAS LONG-ACTING PREP MARKET SIZE, BY MEN WHO HAVE SEX WITH MEN, 2018-2024 (USD MILLION)
TABLE 170. AMERICAS LONG-ACTING PREP MARKET SIZE, BY MEN WHO HAVE SEX WITH MEN, 2025-2030 (USD MILLION)
TABLE 171. AMERICAS LONG-ACTING PREP MARKET SIZE, BY ADMINISTRATION SETTING, 2018-2024 (USD MILLION)
TABLE 172. AMERICAS LONG-ACTING PREP MARKET SIZE, BY ADMINISTRATION SETTING, 2025-2030 (USD MILLION)
TABLE 173. AMERICAS LONG-ACTING PREP MARKET SIZE, BY CLINICAL SETTING, 2018-2024 (USD MILLION)
TABLE 174. AMERICAS LONG-ACTING PREP MARKET SIZE, BY CLINICAL SETTING, 2025-2030 (USD MILLION)
TABLE 175. AMERICAS LONG-ACTING PREP MARKET SIZE, BY HOME BASED, 2018-2024 (USD MILLION)
TABLE 176. AMERICAS LONG-ACTING PREP MARKET SIZE, BY HOME BASED, 2025-2030 (USD MILLION)
TABLE 177. AMERICAS LONG-ACTING PREP MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 178. AMERICAS LONG-ACTING PREP MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 179. UNITED STATES LONG-ACTING PREP MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 180. UNITED STATES LONG-ACTING PREP MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 181. UNITED STATES LONG-ACTING PREP MARKET SIZE, BY IMPLANT, 2018-2024 (USD MILLION)
TABLE 182. UNITED STATES LONG-ACTING PREP MARKET SIZE, BY IMPLANT, 2025-2030 (USD MILLION)
TABLE 183. UNITED STATES LONG-ACTING PREP MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 184. UNITED STATES LONG-ACTING PREP MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 185. UNITED STATES LONG-ACTING PREP MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 186. UNITED STATES LONG-ACTING PREP MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 187. UNITED STATES LONG-ACTING PREP MARKET SIZE, BY COMMUNITY HEALTH CENTERS, 2018-2024 (USD MILLION)
TABLE 188. UNITED STATES LONG-ACTING PREP MARKET SIZE, BY COMMUNITY HEALTH CENTERS, 2025-2030 (USD MILLION)
TABLE 189. UNITED STATES LONG-ACTING PREP MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 190. UNITED STATES LONG-ACTING PREP MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 191. UNITED STATES LONG-ACTING PREP MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 192. UNITED STATES LONG-ACTING PREP MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 193. UNITED STATES LONG-ACTING PREP MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 194. UNITED STATES LONG-ACTING PREP MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 195. UNITED STATES LONG-ACTING PREP MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 196. UNITED STATES LONG-ACTING PREP MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 197. UNITED STATES LONG-ACTING PREP MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 198. UNITED STATES LONG-ACTING PREP MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 199. UNITED STATES LONG-ACTING PREP MARKET SIZE, BY NGOS, 2018-2024 (USD MILLION)
TABLE 200. UNITED STATES LONG-ACTING PREP MARKET SIZE, BY NGOS, 2025-2030 (USD MILLION)
TABLE 201. UNITED STATES LONG-ACTING PREP MARKET SIZE, BY PRIVATE CLINICS, 2018-2024 (USD MILLION)
TABLE 202. UNITED STATES LONG-ACTING PREP MARKET SIZE, BY PRIVATE CLINICS, 2025-2030 (USD MILLION)
TABLE 203. UNITED STATES LONG-ACTING PREP MARKET SIZE, BY PUBLIC HEALTH PROGRAMS, 2018-2024 (USD MILLION)
TABLE 204. UNITED STATES LONG-ACTING PREP MARKET SIZE, BY PUBLIC HEALTH PROGRAMS, 2025-2030 (USD MILLION)
TABLE 205. UNITED STATES LONG-ACTING PREP MARKET SIZE, BY TARGET POPULATION, 2018-2024 (USD MILLION)
TABLE 206. UNITED STATES LONG-ACTING PREP MARKET SIZE, BY TARGET POPULATION, 2025-2030 (USD MILLION)
TABLE 207. UNITED STATES LONG-ACTING PREP MARKET SIZE, BY ADOLESCENTS, 2018-2024 (USD MILLION)
TABLE 208. UNITED STATES LONG-ACTING PREP MARKET SIZE, BY ADOLESCENTS, 2025-2030 (USD MILLION)
TABLE 209. UNITED STATES LONG-ACTING PREP MARKET SIZE, BY HETEROSEXUAL ADULTS, 2018-2024 (USD MILLION)
TABLE 210. UNITED STATES LONG-ACTING PREP MARKET SIZE, BY HETEROSEXUAL ADULTS, 2025-2030 (USD MILLION)
TABLE 211. UNITED STATES LONG-ACTING PREP MARKET SIZE, BY MEN WHO HAVE SEX WITH MEN, 2018-2024 (USD MILLION)
TABLE 212. UNITED STATES LONG-ACTING PREP MARKET SIZE, BY MEN WHO HAVE SEX WITH MEN, 2025-2030 (USD MILLION)
TABLE 213. UNITED STATES LONG-ACTING PREP MARKET SIZE, BY ADMINISTRATION SETTING, 2018-2024 (USD MILLION)
TABLE 214. UNITED STATES LONG-ACTING PREP MARKET SIZE, BY ADMINISTRATION SETTING, 2025-2030 (USD MILLION)
TABLE 215. UNITED STATES LONG-ACTING PREP MARKET SIZE, BY CLINICAL SETTING, 2018-2024 (USD MILLION)
TABLE 216. UNITED STATES LONG-ACTING PREP MARKET SIZE, BY CLINICAL SETTING, 2025-2030 (USD MILLION)
TABLE 217. UNITED STATES LONG-ACTING PREP MARKET SIZE, BY HOME BASED, 2018-2024 (USD MILLION)
TABLE 218. UNITED STATES LONG-ACTING PREP MARKET SIZE, BY HOME BASED, 2025-2030 (USD MILLION)
TABLE 219. UNITED STATES LONG-ACTING PREP MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 220. UNITED STATES LONG-ACTING PREP MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 221. CANADA LONG-ACTING PREP MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 222. CANADA LONG-ACTING PREP MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 223. CANADA LONG-ACTING PREP MARKET SIZE, BY IMPLANT, 2018-2024 (USD MILLION)
TABLE 224. CANADA LONG-ACTING PREP MARKET SIZE, BY IMPLANT, 2025-2030 (USD MILLION)
TABLE 225. CANADA LONG-ACTING PREP MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 226. CANADA LONG-ACTING PREP MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 227. CANADA LONG-ACTING PREP MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 228. CANADA LONG-ACTING PREP MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 229. CANADA LONG-ACTING PREP MARKET SIZE, BY COMMUNITY HEALTH CENTERS, 2018-2024 (USD MILLION)
TABLE 230. CANADA LONG-ACTING PREP MARKET SIZE, BY COMMUNITY HEALTH CENTERS, 2025-2030 (USD MILLION)
TABLE 231. CANADA LONG-ACTING PREP MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 232. CANADA LONG-ACTING PREP MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 233. CANADA LONG-ACTING PREP MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 234. CANADA LONG-ACTING PREP MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 235. CANADA LONG-ACTING PREP MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 236. CANADA LONG-ACTING PREP MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 237. CANADA LONG-ACTING PREP MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 238. CANADA LONG-ACTING PREP MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 239. CANADA LONG-ACTING PREP MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 240. CANADA LONG-ACTING PREP MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 241. CANADA LONG-ACTING PREP MARKET SIZE, BY NGOS, 2018-2024 (USD MILLION)
TABLE 242. CANADA LONG-ACTING PREP MARKET SIZE, BY NGOS, 2025-2030 (USD MILLION)
TABLE 243. CANADA LONG-ACTING PREP MARKET SIZE, BY PRIVATE CLINICS, 2018-2024 (USD MILLION)
TABLE 244. CANADA LONG-ACTING PREP MARKET SIZE, BY PRIVATE CLINICS, 2025-2030 (USD MILLION)
TABLE 245. CANADA LONG-ACTING PREP MARKET SIZE, BY PUBLIC HEALTH PROGRAMS, 2018-2024 (USD MILLION)
TABLE 246. CANADA LONG-ACTING PREP MARKET SIZE, BY PUBLIC HEALTH PROGRAMS, 2025-2030 (USD MILLION)
TABLE 247. CANADA LONG-ACTING PREP MARKET SIZE, BY TARGET POPULATION, 2018-2024 (USD MILLION)
TABLE 248. CANADA LONG-ACTING PREP MARKET SIZE, BY TARGET POPULATION, 2025-2030 (USD MILLION)
TABLE 249. CANADA LONG-ACTING PREP MARKET SIZE, BY ADOLESCENTS, 2018-2024 (USD MILLION)
TABLE 250. CANADA LONG-ACTING PREP MARKET SIZE, BY ADOLESCENTS, 2025-2030 (USD MILLION)
TABLE 251. CANADA LONG-ACTING PREP MARKET SIZE, BY HETEROSEXUAL ADULTS, 2018-2024 (USD MILLION)
TABLE 252. CANADA LONG-ACTING PREP MARKET SIZE, BY HETEROSEXUAL ADULTS, 2025-2030 (USD MILLION)
TABLE 253. CANADA LONG-ACTING PREP MARKET SIZE, BY MEN WHO HAVE SEX WITH MEN, 2018-2024 (USD MILLION)
TABLE 254. CANADA LONG-ACTING PREP MARKET SIZE, BY MEN WHO HAVE SEX WITH MEN, 2025-2030 (USD MILLION)
TABLE 255. CANADA LONG-ACTING PREP MARKET SIZE, BY ADMINISTRATION SETTING, 2018-2024 (USD MILLION)
TABLE 256. CANADA LONG-ACTING PREP MARKET SIZE, BY ADMINISTRATION SETTING, 2025-2030 (USD MILLION)
TABLE 257. CANADA LONG-ACTING PREP MARKET SIZE, BY CLINICAL SETTING, 2018-2024 (USD MILLION)
TABLE 258. CANADA LONG-ACTING PREP MARKET SIZE, BY CLINICAL SETTING, 2025-2030 (USD MILLION)
TABLE 259. CANADA LONG-ACTING PREP MARKET SIZE, BY HOME BASED, 2018-2024 (USD MILLION)
TABLE 260. CANADA LONG-ACTING PREP MARKET SIZE, BY HOME BASED, 2025-2030 (USD MILLION)
TABLE 261. MEXICO LONG-ACTING PREP MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 262. MEXICO LONG-ACTING PREP MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 263. MEXICO LONG-ACTING PREP MARKET SIZE, BY IMPLANT, 2018-2024 (USD MILLION)
TABLE 264. MEXICO LONG-ACTING PREP MARKET SIZE, BY IMPLANT, 2025-2030 (USD MILLION)
TABLE 265. MEXICO LONG-ACTING PREP MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 266. MEXICO LONG-ACTING PREP MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 267. MEXICO LONG-ACTING PREP MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 268. MEXICO LONG-ACTING PREP MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 269. MEXICO LONG-ACTING PREP MARKET SIZE, BY COMMUNITY HEALTH CENTERS, 2018-2024 (USD MILLION)
TABLE 270. MEXICO LONG-ACTING PREP MARKET SIZE, BY COMMUNITY HEALTH CENTERS, 2025-2030 (USD MILLION)
TABLE 271. MEXICO LONG-ACTING PREP MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 272. MEXICO LONG-ACTING PREP MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 273. MEXICO LONG-ACTING PREP MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 274. MEXICO LONG-ACTING PREP MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 275. MEXICO LONG-ACTING PREP MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 276. MEXICO LONG-ACTING PREP MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 277. MEXICO LONG-ACTING PREP MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 278. MEXICO LONG-ACTING PREP MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 279. MEXICO LONG-ACTING PREP MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 280. MEXICO LONG-ACTING PREP MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 281. MEXICO LONG-ACTING PREP MARKET SIZE, BY NGOS, 2018-2024 (USD MILLION)
TABLE 282. MEXICO LONG-ACTING PREP MARKET SIZE, BY NGOS, 2025-2030 (USD MILLION)
TABLE 283. MEXICO LONG-ACTING PREP MARKET SIZE, BY PRIVATE CLINICS, 2018-2024 (USD MILLION)
TABLE 284. MEXICO LONG-ACTING PREP MARKET SIZE, BY PRIVATE CLINICS, 2025-2030 (USD MILLION)
TABLE 285. MEXICO LONG-ACTING PREP MARKET SIZE, BY PUBLIC HEALTH PROGRAMS, 2018-2024 (USD MILLION)
TABLE 286. MEXICO LONG-ACTING PREP MARKET SIZE, BY PUBLIC HEALTH PROGRAMS, 2025-2030 (USD MILLION)
TABLE 287. MEXICO LONG-ACTING PREP MARKET SIZE, BY TARGET POPULATION, 2018-2024 (USD MILLION)
TABLE 288. MEXICO LONG-ACTING PREP MARKET SIZE, BY TARGET POPULATION, 2025-2030 (USD MILLION)
TABLE 289. MEXICO LONG-ACTING PREP MARKET SIZE, BY ADOLESCENTS, 2018-2024 (USD MILLION)
TABLE 290. MEXICO LONG-ACTING PREP MARKET SIZE, BY ADOLESCENTS, 2025-2030 (USD MILLION)
TABLE 291. MEXICO LONG-ACTING PREP MARKET SIZE, BY HETEROSEXUAL ADULTS, 2018-2024 (USD MILLION)
TABLE 292. MEXICO LONG-ACTING PREP MARKET SIZE, BY HETEROSEXUAL ADULTS, 2025-2030 (USD MILLION)
TABLE 293. MEXICO LONG-ACTING PREP MARKET SIZE, BY MEN WHO HAVE SEX WITH MEN, 2018-2024 (USD MILLION)
TABLE 294. MEXICO LONG-ACTING PREP MARKET SIZE, BY MEN WHO HAVE SEX WITH MEN, 2025-2030 (USD MILLION)
TABLE 295. MEXICO LONG-ACTING PREP MARKET SIZE, BY ADMINISTRATION SETTING, 2018-2024 (USD MILLION)
TABLE 296. MEXICO LONG-ACTING PREP MARKET SIZE, BY ADMINISTRATION SETTING, 2025-2030 (USD MILLION)
TABLE 297. MEXICO LONG-ACTING PREP MARKET SIZE, BY CLINICAL SETTING, 2018-2024 (USD MILLION)
TABLE 298. MEXICO LONG-ACTING PREP MARKET SIZE, BY CLINICAL SETTING, 2025-2030 (USD MILLION)
TABLE 299. MEXICO LONG-ACTING PREP MARKET SIZE, BY HOME BASED, 2018-2024 (USD MILLION)
TABLE 300. MEXICO LONG-ACTING PREP MARKET SIZE, BY HOME BASED, 2025-2030 (USD MILLION)
TABLE 301. BRAZIL LONG-ACTING PREP MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 302. BRAZIL LONG-ACTING PREP MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 303. BRAZIL LONG-ACTING PREP MARKET SIZE, BY IMPLANT, 2018-2024 (USD MILLION)
TABLE 304. BRAZIL LONG-ACTING PREP MARKET SIZE, BY IMPLANT, 2025-2030 (USD MILLION)
TABLE 305. BRAZIL LONG-ACTING PREP MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 306. BRAZIL LONG-ACTING PREP MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 307. BRAZIL LONG-ACTING PREP MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 308. BRAZIL LONG-ACTING PREP MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 309. BRAZIL LONG-ACTING PREP MARKET SIZE, BY COMMUNITY HEALTH CENTERS, 2018-2024 (USD MILLION)
TABLE 310. BRAZIL LONG-ACTING PREP MARKET SIZE, BY COMMUNITY HEALTH CENTERS, 2025-2030 (USD MILLION)
TABLE 311. BRAZIL LONG-ACTING PREP MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 312. BRAZIL LONG-ACTING PREP MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 313. BRAZIL LONG-ACTING PREP MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 314. BRAZIL LONG-ACTING PREP MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 315. BRAZIL LONG-ACTING PREP MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 316. BRAZIL LONG-ACTING PREP MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 317. BRAZIL LONG-ACTING PREP MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 318. BRAZIL LONG-ACTING PREP MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 319. BRAZIL LONG-ACTING PREP MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 320. BRAZIL LONG-ACTING PREP MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 321. BRAZIL LONG-ACTING PREP MARKET SIZE, BY NGOS, 2018-2024 (USD MILLION)
TABLE 322. BRAZIL LONG-ACTING PREP MARKET SIZE, BY NGOS, 2025-2030 (USD MILLION)
TABLE 323. BRAZIL LONG-ACTING PREP MARKET SIZE, BY PRIVATE CLINICS, 2018-2024 (USD MILLION)
TABLE 324. BRAZIL LONG-ACTING PREP MARKET SIZE, BY PRIVATE CLINICS, 2025-2030 (USD MILLION)
TABLE 325. BRAZIL LONG-ACTING PREP MARKET SIZE, BY PUBLIC HEALTH PROGRAMS, 2018-2024 (USD MILLION)
TABLE 326. BRAZIL LONG-ACTING PREP MARKET SIZE, BY PUBLIC HEALTH PROGRAMS, 2025-2030 (USD MILLION)
TABLE 327. BRAZIL LONG-ACTING PREP MARKET SIZE, BY TARGET POPULATION, 2018-2024 (USD MILLION)
TABLE 328. BRAZIL LONG-ACTING PREP MARKET SIZE, BY TARGET POPULATION, 2025-2030 (USD MILLION)
TABLE 329. BRAZIL LONG-ACTING PREP MARKET SIZE, BY ADOLESCENTS, 2018-2024 (USD MILLION)
TABLE 330. BRAZIL LONG-ACTING PREP MARKET SIZE, BY ADOLESCENTS, 2025-2030 (USD MILLION)
TABLE 331. BRAZIL LONG-ACTING PREP MARKET SIZE, BY HETEROSEXUAL ADULTS, 2018-2024 (USD MILLION)
TABLE 332. BRAZIL LONG-ACTING PREP MARKET SIZE, BY HETEROSEXUAL ADULTS, 2025-2030 (USD MILLION)
TABLE 333. BRAZIL LONG-ACTING PREP MARKET SIZE, BY MEN WHO HAVE SEX WITH MEN, 2018-2024 (USD MILLION)
TABLE 334. BRAZIL LONG-ACTING PREP MARKET SIZE, BY MEN WHO HAVE SEX WITH MEN, 2025-2030 (USD MILLION)
TABLE 335. BRAZIL LONG-ACTING PREP MARKET SIZE, BY ADMINISTRATION SETTING, 2018-2024 (USD MILLION)
TABLE 336. BRAZIL LONG-ACTING PREP MARKET SIZE, BY ADMINISTRATION SETTING, 2025-2030 (USD MILLION)
TABLE 337. BRAZIL LONG-ACTING PREP MARKET SIZE, BY CLINICAL SETTING, 2018-2024 (USD MILLION)
TABLE 338. BRAZIL LONG-ACTING PREP MARKET SIZE, BY CLINICAL SETTING, 2025-2030 (USD MILLION)
TABLE 339. BRAZIL LONG-ACTING PREP MARKET SIZE, BY HOME BASED, 2018-2024 (USD MILLION)
TABLE 340. BRAZIL LONG-ACTING PREP MARKET SIZE, BY HOME BASED, 2025-2030 (USD MILLION)
TABLE 341. ARGENTINA LONG-ACTING PREP MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 342. ARGENTINA LONG-ACTING PREP MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 343. ARGENTINA LONG-ACTING PREP MARKET SIZE, BY IMPLANT, 2018-2024 (USD MILLION)
TABLE 344. ARGENTINA LONG-ACTING PREP MARKET SIZE, BY IMPLANT, 2025-2030 (USD MILLION)
TABLE 345. ARGE

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Long-acting PrEP market report include:
  • ViiV Healthcare Limited
  • Merck & Co., Inc.
  • Gilead Sciences, Inc.
  • Janssen Pharmaceutica NV
  • Viatris Inc.
  • Teva Pharmaceutical Industries Limited
  • Cipla Limited
  • Lupin Limited
  • Sandoz International GmbH
  • Serum Institute of India Private Limited

Related Reports

Drugs for PrEP Market - Global Forecast 2025-2030 - Product Image

Drugs for PrEP Market - Global Forecast 2025-2030

  • Report
  • 190 Pages
  • Global
From
Parenteral PrEP Market - Global Forecast 2025-2030 - Product Image

Parenteral PrEP Market - Global Forecast 2025-2030

  • Report
  • 187 Pages
  • Global
From
HIV Injections - Global Strategic Business Report - Product Image

HIV Injections - Global Strategic Business Report

  • Report
  • 182 Pages
  • Global
From
Human Immunodeficiency Virus Hiv 1 Infection Market - Product Image

Human Immunodeficiency Virus Hiv 1 Infection Market

  • Report
  • 250 Pages
  • Global
From
Biktarvy Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Image

Biktarvy Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • 150 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.